Dr. Ciafaloni is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
601 Crittenden Blvd
Rochester, NY 14642Phone+1 585-275-4568Fax+1 585-273-1254
Education & Training
Duke University HospitalResidency, Neurology, 1996 - 1998
University of Milan Faculty of MedicineClass of 1989- Duke University HospitalFellowship, Neuromuscular Medicine (Neurology)
Certifications & Licensure
NY State Medical License 2002 - 2026
NC State Medical License 1999 - 2003
VA State Medical License 2001 - 2002- American Board of Psychiatry and Neurology Neurology
- American Board of Psychiatry and Neurology Neuromuscular Medicine
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012
Clinical Trials
- Thymectomy Trial in Non-Thymomatous Myasthenia Gravis Patients Receiving Prednisone Therapy Start of enrollment: 2006 Jun 01
- Characteristics of Andersen-Tawil Syndrome Start of enrollment: 2007 Nov 01
- Finding the Optimum Regimen for Duchenne Muscular Dystrophy Start of enrollment: 2013 Jan 01
- Join now to see all
Publications & Presentations
PubMed
- Latent factors underlying the symptoms of adult-onset myotonic dystrophy type 1 during the clinical course.Yanan Zhang, Bailey Wallace, Bo Cai, Nicholas Johnson, Emma Ciafaloni
Orphanet Journal of Rare Diseases. 2024-11-01 - 3 citationsAAV gene therapy for Duchenne muscular dystrophy: the EMBARK phase 3 randomized trial.Jerry R Mendell, Francesco Muntoni, Craig M McDonald, Eugenio M Mercuri, Emma Ciafaloni
Nature Medicine. 2024-10-09 - Patient- and caregiver-reported impact of symptoms in Duchenne muscular dystrophy.Spencer Rosero, Jennifer Weinstein, Jamison Seabury, Anika Varma, Nuran Dilek
Muscle & Nerve. 2024-07-01
Journal Articles
- Implementation of Duchenne Muscular Dystrophy Care ConsiderationsEmma Ciafaloni, Christopher Cunniff, AAP News
Authored Content
- Implementation of Duchenne Muscular Dystrophy Care ConsiderationsJuly 2018
Press Mentions
Recommendations for Clinical Trial Design in Duchenne Muscular Dystrophy: Emma Ciafaloni, MDOctober 2nd, 2022
COVID-19: Guidelines for Myasthenia Gravis Management and Other Neuromuscular DisordersMay 21st, 2020
Where There Is Debate on the ‘Persuasive Evidence’ That Exon-Skipping Therapies Work for Duchenne Muscular DystrophyAugust 15th, 2019- Join now to see all
Grant Support
- Trial To Assess The Efficacy &Safety Of MMF In Subjects With Myasthenia GravisNational Center For Research Resources2005
- Causes Of Excessive Sleepiness In Myotonic DystrophyNational Center For Research Resources2004–2005
- A Clinical Trial Of Cellcept In The Treatment Of Myasthenia GravisNational Center For Research Resources2004–2005
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
